Breaking News Bar

Business News and Information

One under-the-radar biotech company could be your next big bet in the IPO market, says Renaissance Capital co-founder

Under-the-radar biotechnology company PPD could be worth watching as it gears up for a 2020 initial public offering, says Kathleen Smith, co-founder and chairman at Renaissance Capital.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear